Skip to main content
Top
Published in: BMC Clinical Pharmacology 1/2009

Open Access 01-12-2009 | Research article

Methanol poisoning and long term sequelae – a six years follow-up after a large methanol outbreak

Authors: Raido Paasma, Knut Erik Hovda, Dag Jacobsen

Published in: BMC Clinical Pharmacology | Issue 1/2009

Login to get access

Abstract

Background

Mass poisonings with methanol are rare but occur regularly both in developed and in developing countries. Data from the poisoning episodes are often published, but follow-up-data is scarce. We therefore conducted a six year follow-up study after the large methanol outbreak in Estonia in September 2001.

Methods

Surviving victims from the outbreak were contacted and invited to an interview and a clinical evaluation by an ophthalmologist and a physician. The patients that failed to respond were searched for in the Estonian Register of Population and through their General Practitioner.

Results

During the outbreak in 2001, 86/111 hospitalized patients survived: 66 without sequelae (Group I) and 20 with sequelae (Group II). Six years later, 26/86 were dead, 33/86 could not be tracked down, and so only 27/86 of these were followed up and examined: 22/66 of the patients in Group I, and 5/20 in Group II were found and examined. From Group I, 8/22 were identified with new neurological impairment and 8/22 with new visual disturbances after discharge. From Group II, visual disturbances (n = 4) and neurological impairment (n = 3) were still present in all patients. Among the 26 dead, 19 were from Group I, and seven were from Group II. Alcohol intoxication was the most frequent cause of death (7/26).

Conclusion

All sequelae were still present six years after the initial poisoning suggesting that these were irreversible damages. On follow-up, apparently new neurological and visual complications were identified in 36% and 36%, respectively. 35% of the patients initially discharged with sequelae and 29% discharged without were dead six years later; 27% of them from alcohol intoxication.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jacobsen D, McMartin KE: Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol. 1986, 1: 309-334.CrossRefPubMed Jacobsen D, McMartin KE: Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment. Med Toxicol. 1986, 1: 309-334.CrossRefPubMed
2.
go back to reference Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA: American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002, 40: 415-446. 10.1081/CLT-120006745.CrossRefPubMed Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA: American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol. 2002, 40: 415-446. 10.1081/CLT-120006745.CrossRefPubMed
3.
go back to reference Brent J, McMartin K, Phillips S, Aaron C, Kulig K: Fomepizole for the treatment of methanol poisoning. N Engl J Med. 2001, 344: 424-429. 10.1056/NEJM200102083440605.CrossRefPubMed Brent J, McMartin K, Phillips S, Aaron C, Kulig K: Fomepizole for the treatment of methanol poisoning. N Engl J Med. 2001, 344: 424-429. 10.1056/NEJM200102083440605.CrossRefPubMed
4.
go back to reference Hovda KE, Andersson KS, Urdal P, Jacobsen D: Methanol and formate kinetics during treatment with fomepizole. Clin Toxicol (Phila). 2005, 43 (4): 221-227.CrossRef Hovda KE, Andersson KS, Urdal P, Jacobsen D: Methanol and formate kinetics during treatment with fomepizole. Clin Toxicol (Phila). 2005, 43 (4): 221-227.CrossRef
5.
go back to reference Hovda KE, Froyshov S, Gudmundsdottir H, Rudberg N, Jacobsen D: Fomepizole may change the indication for HD in methanol poisoning: Prospective study in 7 cases. Clin Nephrol. 2005, 64: 190-197.CrossRefPubMed Hovda KE, Froyshov S, Gudmundsdottir H, Rudberg N, Jacobsen D: Fomepizole may change the indication for HD in methanol poisoning: Prospective study in 7 cases. Clin Nephrol. 2005, 64: 190-197.CrossRefPubMed
6.
go back to reference Megarbane B, Borron SW, Baud FJ: Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med. 2005, 31: 189-195. 10.1007/s00134-004-2521-0.CrossRefPubMed Megarbane B, Borron SW, Baud FJ: Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med. 2005, 31: 189-195. 10.1007/s00134-004-2521-0.CrossRefPubMed
7.
go back to reference Hovda KE, Jacobsen D: Expert opinion: fomepizole may ameliorate the need for hemodialysis in methanol poisoning. Hum Exp Toxicol. 2008, 27: 539-546. 10.1177/0960327108095992.CrossRefPubMed Hovda KE, Jacobsen D: Expert opinion: fomepizole may ameliorate the need for hemodialysis in methanol poisoning. Hum Exp Toxicol. 2008, 27: 539-546. 10.1177/0960327108095992.CrossRefPubMed
8.
go back to reference Swartz RD, Millman RP, Billi JE, Bondar NP, Migdal SD, Simonian SK: Epidemic methanol poisoning: clinical and biochemical analysis of a recent episode. Medicine (Baltimore). 1981, 60: 373-382. 10.1097/00005792-198109000-00005.CrossRef Swartz RD, Millman RP, Billi JE, Bondar NP, Migdal SD, Simonian SK: Epidemic methanol poisoning: clinical and biochemical analysis of a recent episode. Medicine (Baltimore). 1981, 60: 373-382. 10.1097/00005792-198109000-00005.CrossRef
9.
go back to reference Paasma R, Hovda KE, Tikkerberi A, Jacobsen D: Methanol mass poisoning in Estonia: Outbreak in 154 patients. Clin Toxicol (Phila). 2007, 45: 152-157.CrossRef Paasma R, Hovda KE, Tikkerberi A, Jacobsen D: Methanol mass poisoning in Estonia: Outbreak in 154 patients. Clin Toxicol (Phila). 2007, 45: 152-157.CrossRef
10.
go back to reference Hovda KE, Hunderi OH, Tafjord AB, Dunlop O, Rudberg N, Jacobsen D: Methanol outbreak in Norway 2002–2004. Epidemiology, clinical features and prognostic signs. J Intern Med. 2005, 258: 181-190. 10.1111/j.1365-2796.2005.01521.x.CrossRefPubMed Hovda KE, Hunderi OH, Tafjord AB, Dunlop O, Rudberg N, Jacobsen D: Methanol outbreak in Norway 2002–2004. Epidemiology, clinical features and prognostic signs. J Intern Med. 2005, 258: 181-190. 10.1111/j.1365-2796.2005.01521.x.CrossRefPubMed
11.
go back to reference Roe O: Clinical investigations of methyl alcohol poisoning with special references to the pathogenesis and treatment of amblyopia. Acta Med Scand. 1943, 63: 558-605. Roe O: Clinical investigations of methyl alcohol poisoning with special references to the pathogenesis and treatment of amblyopia. Acta Med Scand. 1943, 63: 558-605.
12.
go back to reference Hassanian-Moghaddam H, Pajoumand A, Dadgar SM, Shadnia S: Prognostic factors in methanol poisoning. Hum Exp Toxicol. 2007, 26: 583-586. 10.1177/0960327106080077.CrossRefPubMed Hassanian-Moghaddam H, Pajoumand A, Dadgar SM, Shadnia S: Prognostic factors in methanol poisoning. Hum Exp Toxicol. 2007, 26: 583-586. 10.1177/0960327106080077.CrossRefPubMed
13.
go back to reference Liu JJ, Daya MR, Carrasquillo O, Kales SN: Prognostic factors in patients with methanol poisoning. J Toxicol Clin Toxicol. 1998, 36: 175-181.CrossRefPubMed Liu JJ, Daya MR, Carrasquillo O, Kales SN: Prognostic factors in patients with methanol poisoning. J Toxicol Clin Toxicol. 1998, 36: 175-181.CrossRefPubMed
14.
go back to reference Jacobsen D, Jansen H, Wiik-Larsen E, Bredesen JE, Halvorsen S: Studies on methanol poisoning. Acta Med Scand. 1982, 212: 5-10.CrossRefPubMed Jacobsen D, Jansen H, Wiik-Larsen E, Bredesen JE, Halvorsen S: Studies on methanol poisoning. Acta Med Scand. 1982, 212: 5-10.CrossRefPubMed
15.
go back to reference Naraqi S, Dethlefs RF, Slobodniuk RA, Sairere JS: An outbreak of acute methyl alcohol intoxication. Aust N Z J Med. 1979, 9: 65-68.CrossRefPubMed Naraqi S, Dethlefs RF, Slobodniuk RA, Sairere JS: An outbreak of acute methyl alcohol intoxication. Aust N Z J Med. 1979, 9: 65-68.CrossRefPubMed
Metadata
Title
Methanol poisoning and long term sequelae – a six years follow-up after a large methanol outbreak
Authors
Raido Paasma
Knut Erik Hovda
Dag Jacobsen
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Clinical Pharmacology / Issue 1/2009
Electronic ISSN: 1472-6904
DOI
https://doi.org/10.1186/1472-6904-9-5

Other articles of this Issue 1/2009

BMC Clinical Pharmacology 1/2009 Go to the issue